Liquidia Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於公司

公司簡介

公司代碼LQDA

公司名稱Liquidia Corp

上市日期Jul 26, 2018

CEODr. Roger A. Jeffs, Ph.D.

員工數量157

證券類型Ordinary Share

年結日Jul 26

公司地址419 Davis Drive

城市MORRISVILLE

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編27560

電話19193284400

網址https://www.liquidia.com/

公司代碼LQDA

上市日期Jul 26, 2018

CEODr. Roger A. Jeffs, Ph.D.

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Roger A. Jeffs, Ph.D.

Chief Executive Officer, Director

2.12M

-0.30%

Mr. Russell Schundler, J.D.

General Counsel, Secretary

369.92K

-0.29%

Mr. Rajeev Saggar, M.D.

Chief Medical Officer

242.60K

-7.62%

Mr. Scott Moomaw

Chief Commercial Officer

145.57K

-32.69%

Mr. Jason Adair

Chief Business Officer

140.33K

-0.32%

Mr. Michael Kaseta

Chief Financial Officer, Chief Operating Officer

91.78K

-1.24%

Mr. Damian Degoa

Independent Director

66.11K

+38.55%

Mr. Arthur S. Kirsch

Independent Director

50.40K

+57.49%

Ms. Katherine (Katie) Rielly-Gauvin

Independent Director

18.40K

--

Dr. Joanna C. Horobin

Independent Director

13.40K

-27.18%

名稱

名稱/職務

職務

持股

持股變動

Dr. Roger A. Jeffs, Ph.D.

Chief Executive Officer, Director

2.12M

-0.30%

Mr. Russell Schundler, J.D.

General Counsel, Secretary

369.92K

-0.29%

Mr. Rajeev Saggar, M.D.

Chief Medical Officer

242.60K

-7.62%

Mr. Scott Moomaw

Chief Commercial Officer

145.57K

-32.69%

Mr. Jason Adair

Chief Business Officer

140.33K

-0.32%

Mr. Michael Kaseta

Chief Financial Officer, Chief Operating Officer

91.78K

-1.24%

收入明細

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

暫無數據

地區USD

名稱

營收

佔比

United States

14.00M

0.00%

業務

地區

暫無數據

股東統計

更新時間: 8月16日週六

持股股東

股東類型

持股股東

佔比

Caligan Partners, LP

9.43%

Farallon Capital Management, L.L.C.

7.94%

Manning (Paul B.)

7.21%

BlackRock Institutional Trust Company, N.A.

4.95%

The Vanguard Group, Inc.

4.16%

其他

66.31%

持股股東

佔比

Caligan Partners, LP

9.43%

Farallon Capital Management, L.L.C.

7.94%

Manning (Paul B.)

7.21%

BlackRock Institutional Trust Company, N.A.

4.95%

The Vanguard Group, Inc.

4.16%

其他

66.31%

股東類型

持股股東

佔比

Hedge Fund

36.23%

Investment Advisor

15.90%

Investment Advisor/Hedge Fund

12.18%

Individual Investor

11.46%

Research Firm

4.24%

Corporation

2.67%

Private Equity

1.28%

Bank and Trust

0.45%

Pension Fund

0.18%

其他

15.42%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

350

67.92M

79.46%

-5.32M

2025Q1

356

67.75M

79.47%

-4.91M

2024Q4

344

63.62M

75.17%

-10.09M

2024Q3

335

73.31M

89.39%

+16.42M

2024Q2

318

66.67M

87.88%

+4.98M

2024Q1

302

59.34M

79.61%

+7.64M

2023Q4

256

48.15M

70.41%

+4.56M

2023Q3

236

40.52M

62.49%

-5.87M

2023Q2

223

41.12M

63.56%

-6.16M

2023Q1

214

42.01M

65.00%

-5.41M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Caligan Partners, LP

8.12M

9.5%

--

Apr 23, 2025

Farallon Capital Management, L.L.C.

3.99M

4.67%

+700.00K

+21.27%

Mar 31, 2025

Manning (Paul B.)

6.16M

7.21%

+18.40K

+0.30%

Jun 17, 2025

BlackRock Institutional Trust Company, N.A.

4.20M

4.91%

+14.68K

+0.35%

Mar 31, 2025

The Vanguard Group, Inc.

3.45M

4.04%

-94.77K

-2.67%

Mar 31, 2025

Findell Capital Management LLC

2.89M

3.38%

-190.00K

-6.17%

Mar 31, 2025

Opaleye Management Inc.

2.26M

2.64%

+561.86K

+33.09%

Mar 31, 2025

Goldman Sachs & Company, Inc.

779.12K

0.91%

+70.88K

+10.01%

Mar 31, 2025

Jeffs (Roger A)

2.13M

2.49%

+38.56K

+1.85%

Jun 04, 2025

Legend Aggregator LP

1.86M

2.18%

-5.32M

-74.10%

Dec 31, 2024

持股ETF

更新時間: 9月2日週二

機構名稱

佔比

SPDR S&P Pharmaceuticals ETF

2.16%

Virtus LifeSci Biotech Clinical Trials ETF

1.53%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.34%

iShares U.S. Pharmaceuticals ETF

0.44%

iShares Micro-Cap ETF

0.27%

SPDR S&P Kensho New Economies Composite ETF

0.24%

Vanguard US Momentum Factor ETF

0.11%

iShares Russell 2000 Growth ETF

0.08%

Proshares Ultra Russell 2000

0.05%

ProShares UltraPro Russell2000

0.05%

SPDR S&P Pharmaceuticals ETF

佔比2.16%

Virtus LifeSci Biotech Clinical Trials ETF

佔比1.53%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

佔比1.34%

iShares U.S. Pharmaceuticals ETF

佔比0.44%

iShares Micro-Cap ETF

佔比0.27%

SPDR S&P Kensho New Economies Composite ETF

佔比0.24%

Vanguard US Momentum Factor ETF

佔比0.11%

iShares Russell 2000 Growth ETF

佔比0.08%

Proshares Ultra Russell 2000

佔比0.05%

ProShares UltraPro Russell2000

佔比0.05%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Liquidia Corp

21.800USD

Liquidia Corp

21.800

概覽

公司

財務

分析